Report Categories
View AllRecent Articles
View All
Is Genie Gne Stock In A Selling Zone Price At 14.48 Up 2.48 20260406
Is Bank7 Bsvn Stock Volatile Now Price At 40.95 Down 0.29 20260406
Daily Market Overview Sp 500 And Nasdaq Edge Up Dow Dips In Mixed Trade 20260408 1
Is Rezolve AI RZLVW a value trap or a value play Mini Selloff 20260508
The valuation case for Rumble RUMBW that is hard to ignore Bearish Sentiment 20260508
ConocoPhillips COP Share Price Pullback Driven by Middle East Geopolitical DeEscalation and Crude Price Corrections
EVAX Evaxion shares slide 77 as quarterly loss widens missing Wall Street estimates by 42
Crane NXT CXT Slips 140 Testing 3591 Support 20260519
Noodles NDLS Stock Analysis Falls 095 Watching 1185 20260518
Lincoln LINC Stock Today Drops 259 Key Support at 4576 20260519
Ibotta IBTA Gains 386 Support Holds at 3040 20260518
Government Plans Overhaul of CBEC to Ensure Seamless GST Implementation
Feds Powell Vows No Shadow Chair Role but Warsh Dynamics May Complicate Meetings
Prediction Markets Surge as MultiBillionDollar Industry Attracting Predominantly Young Male Participants
Momentus Stock Surges Nearly 300 on Cash Infusion from Private Placement
SP 500 Edges Higher as Healthcare and Technology Lead Communication Services Lags
Sebi Restricts Seven Entities Over Alleged Social Media Stock Recommendations and Rs 58 Crore Gains
ERO Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Higher Copper Prices
Emergent BioSolutions Q1 2026 Earnings EPS Surprise of 183 as the Company Returns to Profitability
GRNT Q1 2026 Earnings Granite Ridge Resources Misses Big as EPS Falls 84 Below Consensus
SWBI Q1 2026 Earnings EPS Beats Estimates Despite Challenging Market Conditions
Universal Health Realty Income Trust UHT Q1 2026 Earnings Solid EPS Amidst Modest Market Response
GEE Group JOB Edges Higher Amid Tight Trading Range
FG Merger II Corp FGMC Holds Steady with Minimal Gain as Price Nears Middle of Range
Gladstone Capital GLAD Gains 13 as YieldDriven Demand Supports BDC Shares
Mereo BioPharma MREO Tests Key Support at 031 After Modest Decline